Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
- PMID: 35380590
- DOI: 10.1001/jama.2022.1425
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
Comment in
-
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-Reply.JAMA. 2022 Apr 5;327(13):1290. doi: 10.1001/jama.2022.1428. JAMA. 2022. PMID: 35380586 Free PMC article. No abstract available.
Comment on
-
Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.JAMA. 2021 Dec 21;326(23):2395-2404. doi: 10.1001/jama.2021.21222. JAMA. 2021. PMID: 34932078 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
